flag peptide has been researched along with Adenocarcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beer, DG; Nambu, Y | 1 |
| Beer, DG; Hamstra, D; Hughes, SJ; Nambu, Y; Orringer, MB; Rehemtulla, A | 1 |
2 other study(ies) available for flag peptide and Adenocarcinoma
| Article | Year |
|---|---|
Altered surface markers in lung cancer. Lack of cell-surface Fas/APO-1 expression in pulmonary adenocarcinoma may allow escape from immune surveillance.
Topics: Adenocarcinoma; Biomarkers, Tumor; Breast Neoplasms; fas Receptor; Female; Flow Cytometry; Humans; Immunoenzyme Techniques; Immunologic Surveillance; Lung Neoplasms; Lymphoma, B-Cell; Microscopy, Confocal; Oligopeptides; Peptides; Transfection; Tumor Cells, Cultured | 2003 |
Lack of cell surface Fas/APO-1 expression in pulmonary adenocarcinomas.
Topics: Adenocarcinoma; Aged; Animals; Antigens, Surface; Apoptosis; Blotting, Northern; Blotting, Southern; Blotting, Western; COS Cells; Cytoplasm; DNA; DNA, Complementary; fas Receptor; Female; Flow Cytometry; Gene Expression; Genetic Vectors; Humans; Immunohistochemistry; Lung Neoplasms; Male; Microscopy, Confocal; Middle Aged; Oligopeptides; Peptides; Polymerase Chain Reaction; RNA, Messenger; Transfection; Tumor Cells, Cultured | 1998 |